Doctor information
Professor Herishanu is a hematologist who heads the Chronic Lympholeukemia Clinic at the Hematology Department of the Ikhilov Medical Center. He is in private practice at the Assuta Clinic, where he specializes in the treatment of chronic lympholeukemia. Before starting therapy, the professor conducts a comprehensive assessment of the patient’s condition and the course of the disease, including the presence of concomitant pathologies and genetic disorders. He individually selects the tactics of work with each patient, which may include close monitoring, chemotherapy and modern biological drugs. If necessary and possible, the professor conducts bone marrow transplantation. This method gives the patient hope for a complete cure from leukemia. The professor also knows modern methods of bone marrow transplantation, including mini-transplantation – a more gentle technology that allows for less aggressive chemotherapy. The professor diagnoses and treats a wide range of oncohematological pathologies, including acute leukemia, lymphoma, multiple myeloma. The main emphasis is placed on targeting and immune therapy – innovative methods of treatment of oncologic blood diseases.
The most common diseases for referral are
- Hodgkin’s lymphoma
- Multiple myeloma
- Non-Hodgkin’s lymphoma
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Chronic lymphoblastic leukemia
- Chronic myeloid leukemia
Education and clinical experience
2021
2018
2016
2008
2004
2000
1997
1997
Academic and scientific activities
Prof. Herishanu teaches hematology at the Faculty of Medicine of Tel Aviv University. In addition, the professor combines medical and teaching activities with scientific work. He is the author of more than 100 publications in hematology. Their topics are:
- CAR-T-cell therapy in lympholeukemia;
- Diagnosis of Hodgkin’s lymphoma and non-Hodgkin’s lymphomas;
- The role of PET in the diagnosis and treatment of follicular lymphoma;
- therapy of chronic lympholeukemia with modern biological drugs;
- toxicity and efficacy of autologous hematopoietic stem cell transplantation in elderly patients with aggressive lymphoma;
- severity of COVID-19 course and mortality from this disease in patients with chronic lympholeukemia;
- chronic lympholeukemia in people over 80 years of age;
- Coronavirus vaccine efficacy in patients with chronic lympholeukemia and multiple myeloma.
Membership in medical associations
- American Hematology Association.
- Israeli Hematology Association.
